Intelence and Velcade drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Intelence (etravirine) and Velcade (bortezomib). Common drug interactions include bone infarction among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Intelence and Velcade. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.

What is Velcade?

Velcade has active ingredients of bortezomib. It is often used in multiple myeloma. eHealthMe is studying from 66,422 Velcade users. Check the latest studies of Velcade.



On Jul, 08, 2026

16 people who take Intelence and Velcade together, and have interactions are studied.

Intelence and Velcade drug interactions.

What are the common drug interactions of Intelence and Velcade, by gender? *:

female:

  1. Bone infarction (ischemic death of the cellular elements of the bone and marrow)
  2. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  3. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  4. Cardiac failure congestive
  5. Cardiomyopathy (weakening of the heart muscle)
  6. Cerebral atrophy (decrement in size of brain)
  7. Cerumen impaction
  8. Concomitant disease progression (progress in accompanying disease)
  9. Conjunctival haemorrhage (bleeding underneath the conjunctiva)
  10. Conjunctivitis (pink eye)

male:

  1. Anaemia (lack of blood)
  2. Abdominal pain
  3. Eustachian tube dysfunction (eustachian tube problems like clearing the ears when flying, suffering infection, and recurring ear infection)
  4. Facial pain
  5. Gingival pain (gum pain)
  6. Glycosuria (excretion of glucose into the urine)
  7. Headache (pain in head)
  8. Hyperglycaemia (high blood sugar)
  9. Hypertension (high blood pressure)
  10. Hypoacusis (loss of hearing)

What are the common drug interactions of Intelence and Velcade, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Anaemia (lack of blood)
  2. Cardiac failure
  3. Pericardial effusion (fluid around the heart)
  4. Pyrexia (fever)
  5. Renal failure (kidney dysfunction)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Viral load increased
  8. Dizziness
  9. Facial bones fracture (bone fracture of face)
  10. Fall

What are the existing conditions these people have? *

  1. Hiv Infection: 2 people, 12.50%
  2. High Blood Pressure: 2 people, 12.50%
  3. Pain: 1 person, 6.25%
  4. Haemoglobin Abnormal: 1 person, 6.25%
  5. Back Pain: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Intelence and Velcade?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Intelence and Velcade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Intelence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Velcade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Intelence and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Velcade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on etravirine and bortezomib (the active ingredients of Intelence and Velcade, respectively), and Intelence and Velcade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: